Literature DB >> 8736654

Study of paradoxical response to chemotherapy in tuberculous pleural effusion.

S A Al-Majed1.   

Abstract

BACKGROUND: Paradoxical worsening of disease, in spite of effective chemotherapy for tuberculosis, has been reported to occur in cases of intracranial tuberculoma, lymph node, and pulmonary tuberculosis. However, only rare case reports describe such paradoxical response in tuberculosis pleurisy.
METHODS: Sixty-one patients with proven tuberculous pleural effusion were retrospectively screened in Riyadh, Saudi Arabia, in three major hospitals to look systematically at the incidence and features of paradoxical response.
RESULTS: Paradoxical increase in the size of the effusion was detected in 10 of 61 patients. In six patients, the effusion became massive with worsening of dyspnoea requiring the use of corticosteroids in five patients and therapeutic aspiration in all six. However, complete resolution occurred in all 10 patients within 1-3 months. Three out of the 10 patients developed residual pleural thickening.
CONCLUSION: An incidence of 16% (10/61) paradoxical worsening of tuberculous effusion following the start of anti-tuberculous treatment has been documented. This resulted in respiratory distress necessitating therapeutic re-aspiration in six of 10 patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8736654     DOI: 10.1016/s0954-6111(96)90289-9

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

1.  Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients.

Authors:  V C C Cheng; W C Yam; P C Y Woo; S K P Lau; I F N Hung; S P Y Wong; W C Cheung; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-24       Impact factor: 3.267

2.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

Review 3.  Tuberculous Pleural Effusion.

Authors:  Leah A Cohen; Richard W Light
Journal:  Turk Thorac J       Date:  2015-01-01

4.  A Case of Obstructive Jaundice Caused by Paradoxical Reaction during Antituberculous Chemotherapy for Abdominal Tuberculosis.

Authors:  Yun Jung Lee; Sung Hee Jung; Woo Jin Hyun; Sae Hee Kim; Hyang Ie Lee; Hyeon Woong Yang; Anna Kim; Sang Woo Cha
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

Review 5.  Tuberculous pleural effusion.

Authors:  Kan Zhai; Yong Lu; Huan-Zhong Shi
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  A patient on RIPE therapy presenting with recurrent isoniazid-associated pleural effusions: a case report.

Authors:  Vanja Varenika; Paul D Blanc
Journal:  J Med Case Rep       Date:  2011-11-30

7.  Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients.

Authors:  G Geri; A Passeron; B Heym; J-B Arlet; J Pouchot; L Capron; B Ranque
Journal:  Infection       Date:  2012-12-01       Impact factor: 3.553

8.  Clinical significance of Glasgow Prognostic Score in patients with tuberculous pleurisy.

Authors:  Hye Seon Kang; Hwa Young Lee; Jung Im Jung; Ju Sang Kim; Yong Hyun Kim; Seung Joon Kim; Seok Chan Kim; Soon Seog Kwon; Young Kyoon Kim; Ji Young Kang
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

9.  Isoniazid causing pleural effusion.

Authors:  S K Singh; Z Ahmad; D K Pandey; V Gupta; S Naaz
Journal:  Indian J Pharmacol       Date:  2008-03       Impact factor: 1.200

10.  Contra-lateral paradoxical pleural effusion during antituberculous chemotherapy.

Authors:  Vishal Chopra; Urvinderpal Singh; Dimple Chopra
Journal:  Lung India       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.